NCT06117878 2023-11-07
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Unknown
Base Therapeutics (Shanghai) Co., Ltd.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Lee's Pharmaceutical Limited
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Alaunos Therapeutics